CMPS COMPASS Pathways Plc - American Depository Shares

NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗
$13,61
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$4–$15
84% of range
Analystenbewertung
BUY
24 analysts
Kursziel
$24
+75% upside
P/E (TTM)
-4.4
ROE
-524.8%
Nettogewinnmarge
—

Über COMPASS Pathways Plc - American Depository Shares Unternehmensübersicht von Wikipedia

Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).

Mehr lesen

Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).

Compass Pathways is the largest company in the psychedelic medicine industry and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. It has faced criticism for patenting psychedelic drugs and even certain psilocybin mushroom species. In October 2024, after the FDA rejected Lykos Therapeutics's MDMA for post-traumatic stress disorder (PTSD) New Drug Application (NDA), Compass Pathways said that it would lay off 30% of its workforce and narrow its research focus.

Compass Pathways has entered partnerships with several independent psychedelic academic scientists, including Jason Wallach, Hamilton Morris, and Adam Halberstadt among others, to develop novel psychedelic drugs for potential medical use. Wallach's lab is said to have sought patents for over 200 novel compounds as of May 2024.

Compass Pathways switched from being a nonprofit organization to a for-profit company in 2016. The pharmaceutical company has been backed and funded by a number of tech entrepreneurs such as Peter Thiel. The media outlet Sifted remarks that the biotech billionaire Christian Angermayer was instrumental in the founding of Compass Pathways."

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

CMPS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$13.61
Marktkapitalisierung
$1.31B
P/E (TTM)
-4.4
EPS (TTM)
$-3.08
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-524.8%
Verschuldungsgrad
-0.6
52W-Spanne
$4 – $15

CMPS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis —
EPS $-3.08
7-point trend, -17.6%
2019-12-31 → 2025-12-31
Freier Cashflow —
4-point trend, -75.1%
2021-12-31 → 2024-12-31
Margen —

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
CMPS
Peer-Median
P/E (TTM)
5-point trend, +81.9%
-4.4
66.9
P/B (K/B)
2-point trend, -848.9%
-24.7
3.7
EV / EBITDA
2-point trend, -336.8%
-6.6
—

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
CMPS
Peer-Median
ROA
5-point trend, -377.3%
-135.8%
-23.9%
ROE
5-point trend, -2056.9%
-524.8%
-27.7%
ROIC
5-point trend, +2951.8%
836.7%
—

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
CMPS
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
2-point trend, -407.0%
-0.6
4.4
Current Ratio (Liquiditätsgrad)
5-point trend, -96.0%
0.8
4.0
Quick Ratio
5-point trend, -96.7%
0.6
—

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
CMPS
Peer-Median

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
CMPS
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, -72.1%
$-3.08
—

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
CMPS
Peer-Median

CMPS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 24 Analysten
  • Starker Kauf 8 33,3%
  • Kauf 14 58,3%
  • Halten 2 8,3%
  • Verkauf 0 0,0%
  • Starker Verkauf 0 0,0%

12-Monats-Kursziel

16 Analysten · 2026-08-16
Median-Ziel $21.00 +54,3%
Mittelwert-Ziel $23.75 +74,5%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
-0.27%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $-1.88 $-0.41 -1.5%
31. März 2026 $0.71 $-0.39 1.1%
31. Dezember 2025 $-1.00 $-0.40 -0.60%
30. September 2025 $-1.44 $-0.40 -1.0%
30. Juni 2025 $-0.41 $-0.44 0.03%
31. März 2025 $-0.38 $-0.48 0.10%
31. Dezember 2024 $-0.63 $-0.64 0.01%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
CMPS $663M -2.2 — — -524.8% —
ROIV $19.95B -51.3 -71.6% -3629.2% -6.5% —
BDRX — — — — — —
KNSA $3.15B 55.0 60.1% 8.7% 11.1% —
IMCR $1.76B -48.9 28.9% -8.9% -9.2% —
AUTL — -1.8 644.9% -381.4% -109.6% —

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 15
Jährliche Gewinn- und Verlustrechnung-Daten für CMPS
Kennzahl Trend 202520242023202220212020
R&D Expense 6-point trend, +406.9% $118M $119M $88M $65M $44M $23M
SG&A Expense 6-point trend, +116.2% $61M $59M $49M $45M $39M $28M
Operating Expenses 6-point trend, +248.4% $179M $178M $137M $110M $83M $51M
Operating Income 6-point trend, -248.4% $-179M $-178M $-137M $-110M $-83M $-51M
Interest Expense 3-point trend, +2204000.00 · · $2M $0 $0 ·
Interest Income 3-point trend, +55.4% $7M $8M $5M · · ·
Other Non-op 6-point trend, +115.5% $1M $823.0K $255.0K $19M $12M $-9M
Pretax Income 6-point trend, -381.5% $-290M $-154M $-118M $-91M $-72M $-60M
Income Tax 6-point trend, -7828.1% $-2M $2M $780.0K $408.0K $199.0K $32.0K
Net Income 6-point trend, -377.1% $-288M $-155M $-118M $-92M $-72M $-60M
EPS (Basic) 6-point trend, +13.2% $-3.08 $-2.30 $-2.32 $-2.16 $-1.79 $-3.55
EPS (Diluted) 6-point trend, +13.2% $-3.08 $-2.30 $-2.32 $-2.16 $-1.79 $-3.55
Shares (Basic) 6-point trend, +450.3% 93,504,836 67,482,902 51,028,024 42,436,292 39,997,587 16,991,664
Shares (Diluted) 6-point trend, +450.3% 93,504,836 67,482,902 51,028,024 42,436,292 39,997,587 16,991,664
EBITDA 5-point trend, -115.6% $-179M $-178M $-137M $-110M $-83M ·
Bilanz 22
Jährliche Bilanz-Daten für CMPS
Kennzahl Trend 202520242023202220212020
Cash & Equivalents 6-point trend, -21.4% $150M $165M $220M $143M $273M $190M
Prepaid Expense 6-point trend, +244.5% $42M $36M $41M $48M $22M $12M
Other Current Assets 6-point trend, +996.3% $6M $4M $2M $1M $1M $509.0K
Current Assets 6-point trend, -5.4% $191M $201M $261M $192M $295M $202M
PP&E (Net) 5-point trend, -22.9% · $189.0K $423.0K $617.0K $398.0K $245.0K
PP&E (Gross) 3-point trend, +164.9% · · · $1M $756.0K $433.0K
Accum. Depreciation 3-point trend, +181.9% · · · $530.0K $358.0K $188.0K
Other Non-current Assets 6-point trend, +20398.2% $12M $7M $7M $1M $213.0K $57.0K
Total Assets 6-point trend, +3.4% $210M $214M $276M $197M $301M $203M
Accounts Payable 6-point trend, +454.1% $15M $12M $6M $5M $3M $3M
Current Liabilities 6-point trend, +3493.8% $248M $34M $20M $16M $15M $7M
Capital Leases 5-point trend, -6.3% $1M $303.0K $2M $418.0K $1M ·
Total Liabilities 6-point trend, +3717.2% $263M $59M $50M $16M $16M $7M
Long-term Debt 4-point trend, +31633000.00 $32M $30M $29M $0 · ·
Total Debt 2-point trend, +4.9% $32M $30M · · · ·
Common Stock 3-point trend, +53.2% $973.0K $702.0K $635.0K · · ·
Paid-in Capital 6-point trend, +180.4% $784M $705M $622M $459M $445M $279M
Retained Earnings 6-point trend, -740.2% $-823M $-535M $-380M $-261M $-170M $-98M
AOCI 6-point trend, -201.4% $-15M $-16M $-17M $-17M $9M $15M
Stockholders' Equity 6-point trend, -126.9% $-53M $155M $226M $181M $284M $197M
Liabilities + Equity 6-point trend, +3.4% $210M $214M $276M $197M $301M $203M
Shares Outstanding 3-point trend, +55.1% 96,085,785 68,552,215 61,943,471 · · ·
Cashflow 16
Jährliche Cashflow-Daten für CMPS
Kennzahl Trend 202520242023202220212020
D&A 4-point trend, +116.1% · · $242.0K $330.0K $175.0K $112.0K
Stock-based Comp 6-point trend, -24.4% $14M $20M $17M $13M $9M $18M
Deferred Tax 6-point trend, +110.0% $22.0K $-437.0K $-1M $-1M $-545.0K $-221.0K
Other Non-cash 3-point trend, +209.6% · · $5M $-26M $-4M ·
Operating Cash Flow 6-point trend, -280.0% $-157M $-119M $-97M $-105M $-68M $-41M
CapEx 5-point trend, -100.0% · $0 $66.0K $596.0K $334.0K $131.0K
Investing Cash Flow 5-point trend, +100.0% · $0 $-64.0K $-596.0K $-334.0K $-628.0K
Debt Issued 4-point trend, +0.00 · $0 $30M $0 $0 ·
Net Debt Issued 2-point trend, -100.0% · $0 $30M · · ·
Stock Issued 6-point trend, +140357000.00 $140M $26M $145M $440.0K $155M $0
Net Stock Activity 5-point trend, -9.3% $140M $26M $145M $440.0K $155M ·
Financing Cash Flow 6-point trend, -27.5% $141M $64M $174M $1M $157M $194M
Net Change in Cash 6-point trend, -109.4% $-15M $-55M $77M $-130M $83M $165M
Taxes Paid $755.0K · · · · ·
Free Cash Flow 4-point trend, -75.1% · $-119M $-97M $-106M $-68M ·
Levered FCF · · $-100M · · ·
Rentabilität 3
Jährliche Rentabilität-Daten für CMPS
Kennzahl Trend 202520242023202220212020
ROA 5-point trend, -377.3% -135.8% -63.4% -50.1% -36.7% -28.4% ·
ROE 5-point trend, -2056.9% -524.8% -89.2% -49.5% -48.7% -24.3% ·
ROIC 5-point trend, +2951.8% 836.7% -97.4% -61.1% -61.2% -29.3% ·
Liquidität & Solvenz 5
Jährliche Liquidität & Solvenz-Daten für CMPS
Kennzahl Trend 202520242023202220212020
Current Ratio 5-point trend, -96.0% 0.8 5.9 13.3 12.3 19.5 ·
Quick Ratio 5-point trend, -96.7% 0.6 4.9 11.2 9.2 18.1 ·
Debt / Equity 2-point trend, -407.0% -0.6 0.2 · · · ·
LT Debt / Equity 2-point trend, -267.5% -0.3 0.2 · · · ·
Interest Coverage · · -62.1 · · ·
Pro Aktie 4
Jährliche Pro Aktie-Daten für CMPS
Kennzahl Trend 202520242023202220212020
Book Value / Share 2-point trend, -124.4% $-0.55 $2.26 · · · ·
Cash Flow / Share 5-point trend, +0.7% $-1.68 $-1.77 $-1.91 $-2.48 $-1.69 ·
Cash / Share 2-point trend, -35.3% $1.56 $2.41 · · · ·
EPS (TTM) 5-point trend, -72.1% $-3.08 $-2.30 $-2.32 $-2.16 $-1.79 ·
Bewertung (TTM) 11
Jährliche Bewertung (TTM)-Daten für CMPS
Kennzahl Trend 202520242023202220212020
Net Income TTM 5-point trend, -301.2% $-288M $-155M $-118M $-92M $-72M ·
Market Cap 2-point trend, +155.9% $663M $259M · · · ·
Enterprise Value 2-point trend, +338.8% $545M $124M · · · ·
P/E 5-point trend, +81.9% -2.2 -1.6 -3.8 -3.7 -12.3 ·
P/B 2-point trend, -848.9% -12.5 1.7 · · · ·
P / Tangible Book · 1.7 · · · ·
P / Cash Flow 2-point trend, -93.9% -4.2 -2.2 · · · ·
P / FCF · -2.2 · · · ·
EV / EBITDA 2-point trend, -336.8% -3.0 -0.7 · · · ·
EV / FCF · -1.0 · · · ·
Earnings Yield 5-point trend, -451.1% -44.6% -60.9% -26.5% -26.9% -8.1% ·

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312022-12-312021-12-31
Nettoergebnis $-288M$-155M$-118M$-92M$-72M
Verwässerte EPS $-3.08$-2.30$-2.32$-2.16$-1.79
Bilanz
2025-12-312024-12-312023-12-312022-12-312021-12-31
Fremdkapital / Eigenkapital -0.60.2———
Liquiditätsgrad 0.85.913.312.319.5
Quick Ratio 0.64.911.29.218.1
Cashflow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Freier Cashflow —$-119M$-97M$-106M$-68M

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 250 Einreicher · $1.3B gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
66 (+6 vs. Vorquartal) 30 (+7 vs. Vorquartal) 77 (+3 vs. Vorquartal) 53 (+26 vs. Vorquartal) -2.0M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
Deep Track Capital, LP $172.085.168 12.161.496 13,73% Aktien
RTW INVESTMENTS, LP $151.418.782 10.700.974 12,08% Aktien
BIT Capital GmbH $89.835.478 6.348.797 7,17% Aktien
TANG CAPITAL MANAGEMENT LLC $70.750.000 5.000.000 5,65% Aktien
TWO SIGMA INVESTMENTS, LP $63.257.363 4.470.485 5,05% Aktien
ARK Investment Management LLC $48.845.310 3.451.965 3,90% Aktien
Point72 Asset Management, L.P. $37.085.424 2.620.878 2,96% Aktien
Logos Global Management LP $31.837.500 2.250.000 2,54% Aktien
Eagle Health Investments LP $29.155.042 2.060.427 2,33% Aktien
DAFNA Capital Management LLC $28.469.121 2.011.952 2,27% Aktien
BANK OF AMERICA CORP /DE/ $28.339.691 2.002.805 2,26% Aktien
Caption Management, LLC $27.544.390 1.946.600 2,20% Kaufoption
SUSQUEHANNA INTERNATIONAL GROUP, LLP $26.855.285 1.897.900 2,14% Kaufoption
NEXTBio Capital Management LP $25.126.990 1.775.759 2,00% Aktien
MARSHALL WACE, LLP $20.935.350 1.479.530 1,67% Aktien
Aisling Capital Management LP $20.267.554 1.432.336 1,62% Aktien
RENAISSANCE TECHNOLOGIES LLC $20.261.229 1.431.889 1,62% Aktien
Candriam S.C.A. $18.013.686 1.274.278 1,44% Aktien
Woodline Partners LP $15.366.957 1.086.004 1,23% Aktien
Jefferies Financial Group Inc. $14.070.661 994.393 1,12% Aktien
Trexquant Investment LP $12.171.236 860.158 0,97% Aktien
Kalehua Capital Management LLC $11.598.642 819.692 0,93% Aktien
MILLENNIUM MANAGEMENT LLC $10.909.466 770.987 0,87% Aktien
Caption Management, LLC $10.699.041 756.116 0,85% Aktien
Eversept Partners, LP $9.520.474 672.825 0,76% Aktien
Propel Bio Management, LLC $8.109.167 573.086 0,65% Aktien
Creek Drive Management Group LLC $8.093.800 572.000 0,65% Aktien
Occam Crest Management LP $7.739.000 710.000 0,62% Aktien
CITADEL ADVISORS LLC $7.567.420 534.800 0,60% Kaufoption
SUSQUEHANNA INTERNATIONAL GROUP, LLP $7.140.090 504.600 0,57% Verkaufsoption
SILVERARC CAPITAL MANAGEMENT, LLC $7.122.855 503.382 0,57% Aktien
JANE STREET GROUP, LLC $7.075.821 500.058 0,56% Aktien
Qube Research & Technologies Ltd $7.070.415 499.676 0,56% Aktien
Walleye Capital LLC $6.893.385 487.165 0,55% Aktien
Ensign Peak Advisors, Inc $6.716.340 474.653 0,54% Aktien
Blue Owl Capital Holdings LP $6.367.500 450.000 0,51% Aktien
AdvisorShares Investments LLC $5.962.060 421.347 0,48% Aktien
CITADEL ADVISORS LLC $5.952.679 420.684 0,47% Aktien
TWO SIGMA ADVISERS, LP $5.909.850 856.500 0,47% Aktien
GOLDMAN SACHS GROUP INC $5.540.956 391.587 0,44% Aktien
HighVista Strategies LLC $5.251.349 371.120 0,42% Aktien
Legal & General Group Plc $4.700.154 332.206 0,38% Aktien
Sumitomo Mitsui Trust Group, Inc. $4.573.407 323.209 0,36% Aktien
Amova Asset Management Americas, Inc. $4.517.334 319.472 0,36% Aktien
Squadron Capital Management LLC $4.315.750 305.000 0,34% Kaufoption
Affinity Asset Advisors, LLC $4.261.739 301.183 0,34% Aktien
SEVEN GRAND MANAGERS, LLC $4.245.000 300.000 0,34% Aktien
ADAGE CAPITAL PARTNERS GP, L.L.C. $4.245.000 300.000 0,34% Aktien
Squadron Capital Management LLC $4.245.000 300.000 0,34% Aktien
AMERIPRISE FINANCIAL INC $4.081.271 288.429 0,33% Aktien
JANE STREET GROUP, LLC $4.079.445 288.300 0,33% Kaufoption
STEMPOINT CAPITAL LP $4.029.481 284.769 0,32% Aktien
TORONTO DOMINION BANK $3.930.233 277.755 0,31% Aktien
ROYCE & ASSOCIATES LP $3.778.885 267.059 0,30% Aktien
PFM Health Sciences, LP $3.503.384 247.589 0,28% Aktien
D. E. Shaw & Co., Inc. $3.408.367 240.874 0,27% Aktien
Brown University $3.030.930 214.200 0,24% Aktien
MORGAN STANLEY $2.973.693 210.155 0,24% Aktien
Caption Management, LLC $2.950.275 208.500 0,24% Verkaufsoption
HEIGHTS CAPITAL MANAGEMENT, INC $2.913.938 205.932 0,23% Aktien
CITADEL ADVISORS LLC $2.695.575 190.500 0,22% Verkaufsoption
IQ EQ FUND MANAGEMENT (IRELAND) Ltd $2.481.528 175.373 0,20% Aktien
Engineers Gate Manager LP $2.432.343 171.897 0,19% Aktien
Y-Intercept (Hong Kong) Ltd $2.378.474 168.090 0,19% Aktien
DISCOVERY CAPITAL MANAGEMENT, LLC / CT $2.122.500 150.000 0,17% Aktien
Squarepoint Ops LLC $1.962.195 138.671 0,16% Aktien
Balyasny Asset Management L.P. $1.959.492 138.480 0,16% Aktien
ALPS ADVISORS INC $1.930.937 136.462 0,15% Aktien
Founders Fund VII Management, LLC $1.924.272 278.880 0,15% Aktien
K2 PRINCIPAL FUND, L.P. $1.911.665 135.100 0,15% Aktien
WELLS FARGO & COMPANY/MN $1.897.246 134.081 0,15% Aktien
CenterBook Partners LP $1.777.155 125.594 0,14% Aktien
Creek Drive Management Group LLC $1.698.000 120.000 0,14% Kaufoption
BANK OF MONTREAL /CAN/ $1.686.991 119.222 0,13% Aktien
ENVESTNET ASSET MANAGEMENT INC $1.639.118 115.839 0,13% Aktien
Palo Alto Investors LP $1.635.966 115.616 0,13% Aktien
Simplify Asset Management Inc. $1.617.076 114.281 0,13% Aktien
LPL Financial LLC $1.550.387 109.568 0,12% Aktien
GROUP ONE TRADING LLC $1.390.917 98.298 0,11% Aktien
Susquehanna Portfolio Strategies, LLC $1.341.448 94.802 0,11% Aktien
CreativeOne Wealth, LLC $1.336.312 94.439 0,11% Aktien
STABLEFORD CAPITAL II LLC $1.300.003 91.873 0,10% Aktien
STATE STREET CORP $1.150.098 81.279 0,09% Aktien
Lion Point Capital, LP $1.132.000 80.000 0,09% Aktien
GEODE CAPITAL MANAGEMENT, LLC $1.063.896 75.187 0,08% Aktien
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. $1.016.635 71.847 0,08% Aktien
DLD Asset Management, LP $990.500 70.000 0,08% Verkaufsoption
SUSQUEHANNA INTERNATIONAL GROUP, LLP $941.852 66.562 0,08% Aktien
Aquatic Capital Management LLC $922.297 65.180 0,07% Aktien
JANE STREET GROUP, LLC $915.505 64.700 0,07% Verkaufsoption
Dorsey Wright & Associates $883.653 62.449 0,07% Aktien
Campbell & CO Investment Adviser LLC $874.696 61.816 0,07% Aktien
STIFEL FINANCIAL CORP $855.639 60.469 0,07% Aktien
Intellectus Partners, LLC $841.925 59.500 0,07% Aktien
DCF Advisers, LLC $767.638 54.250 0,06% Aktien
CIBC WORLD MARKET INC. $737.357 52.110 0,06% Aktien
NATIONAL BANK OF CANADA /FI/ $731.420 51.727 0,06% Aktien
FLAX POND CAPITAL, LLC $728.951 51.516 0,06% Aktien
EXCHANGE TRADED CONCEPTS, LLC $708.943 50.102 0,06% Aktien
PEAK6 LLC $707.500 50.000 0,06% Kaufoption

Unternehmensinsider 9 Insider · 0 Führungskräfte · 0 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Kabir Nath — 3. August 2026 F 361.028 0 0 $0
Robert Mcquade — 27. Mai 2026 A — 0 0 $0
Kathleen Tregoning — 27. Mai 2026 A — 0 0 $0
Daphne Karydas — 27. Mai 2026 A — 0 0 $0
Justin D. Gover — 27. Mai 2026 A — 0 0 $0
David Y Norton — 27. Mai 2026 A — 0 0 $0
Wayne Joseph Riley — 27. Mai 2026 A — 0 0 $0
Gino Santini — 27. Mai 2026 A — 0 0 $0
Jeffrey M Jonas — 27. Mai 2026 A — 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 1 Beteiligung

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
AtaiBeckley Inc. 17. Februar 2026 4,96% Änderung — SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 6 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
ARKG · ARK ETF Trust 2,43% 3.316.076 NS 30. April 2026 N-PORT
BBC · ETFis Series Trust I 0,99% 40.950 NS 30. April 2026 N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust … 0,12% 7.246 SH 8. August 2026 Täglich
IBB · iShares Trust 0,11% 797.974 SH 8. August 2026 Täglich
BIB · ProShares Trust 0,06% 3.487 NS 31. Mai 2026 N-PORT
APIE · Trust for Professional Managers 0,03% 21.455 NS 31. Mai 2026 N-PORT